Ana Griciuc

2.5k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

Ana Griciuc is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Ana Griciuc has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Ana Griciuc's work include Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Retinal Development and Disorders (5 papers). Ana Griciuc is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Retinal Development and Disorders (5 papers). Ana Griciuc collaborates with scholars based in United States, Germany and France. Ana Griciuc's co-authors include Rudolph E. Tanzi, Se Hoon Choi, Basavaraj Hooli, Antonio Parrado, Alberto Serrano‐Pozo, Kristina Mullin, Bradley T. Hyman, Marius Ueffing, Liviu Aron and D. McGinty and has published in prestigious journals such as Neuron, Journal of Neuroscience and Nature reviews. Neuroscience.

In The Last Decade

Ana Griciuc

18 papers receiving 1.6k citations

Hit Papers

Alzheimer’s Disease Risk ... 2013 2026 2017 2021 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
    2013 765 citations Ana Griciuc, Alberto Serrano‐Pozo et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Griciuc United States 12 845 803 558 359 259 19 1.6k
Tomomi Kiyota United States 21 882 1.0× 838 1.0× 518 0.9× 246 0.7× 282 1.1× 34 1.8k
Erin G. Reed-Geaghan United States 16 907 1.1× 761 0.9× 507 0.9× 477 1.3× 189 0.7× 20 1.8k
Nicholas H. Varvel United States 18 1.1k 1.3× 867 1.1× 584 1.0× 417 1.2× 222 0.9× 26 2.1k
Carlo Sala Frigerio United Kingdom 20 915 1.1× 864 1.1× 1.0k 1.8× 361 1.0× 180 0.7× 42 2.3k
Honghua Zheng China 21 1.1k 1.3× 756 0.9× 650 1.2× 704 2.0× 166 0.6× 46 2.2k
Michael A. Mastrangelo United States 21 717 0.8× 968 1.2× 558 1.0× 154 0.4× 234 0.9× 27 1.8k
Yuka Atagi United States 12 894 1.1× 849 1.1× 522 0.9× 514 1.4× 113 0.4× 13 1.8k
Brandy Wilkinson United States 8 474 0.6× 828 1.0× 581 1.0× 233 0.6× 97 0.4× 11 1.6k
Oscar Harari United States 21 725 0.9× 548 0.7× 557 1.0× 374 1.0× 110 0.4× 54 1.6k
Jessica Koenigsknecht-Talboo United States 9 1.1k 1.3× 1.4k 1.7× 633 1.1× 412 1.1× 204 0.8× 9 2.3k

Countries citing papers authored by Ana Griciuc

Since Specialization
Citations

This map shows the geographic impact of Ana Griciuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Griciuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Griciuc more than expected).

Fields of papers citing papers by Ana Griciuc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Griciuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Griciuc. The network helps show where Ana Griciuc may publish in the future.

Co-authorship network of co-authors of Ana Griciuc

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Griciuc. A scholar is included among the top collaborators of Ana Griciuc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Griciuc. Ana Griciuc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Piłat, Dominika, Dmitry Prokopenko, Chih‐Chung Lin, et al.. (2025). The gain-of-function TREM2-T96K mutation increases risk for Alzheimer’s disease by impairing microglial function. Neuron. 114(1). 46–66.e13.
2.
Gao, Jingjing, Ziting Xia, Hao Chen, et al.. (2024). Gene therapy for CNS disorders: modalities, delivery and translational challenges. Nature reviews. Neuroscience. 25(8). 553–572. 41 indexed citations
3.
Yeganeh, Pourya Naderi, Mehdi Jorfi, Djuna von Maydell, et al.. (2024). Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer’s disease. Neuron. 113(2). 205–224.e8. 8 indexed citations
4.
Podvin, Sonia, Barry Greenberg, Jeremiah D. Momper, et al.. (2023). Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease. Frontiers in Pharmacology. 14. 1190402–1190402. 12 indexed citations
5.
Liang, Yingxia, David Y.W. Lee, Haoqi Sun, et al.. (2022). Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease. Phytomedicine. 104. 154158–154158. 7 indexed citations
6.
Griciuc, Ana & Rudolph E. Tanzi. (2021). The role of innate immune genes in Alzheimer's disease. Current Opinion in Neurology. 34(2). 228–236. 129 indexed citations
7.
Shoup, Timothy M., Ana Griciuc, Marc D. Normandin, et al.. (2021). Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer’s Disease. Journal of Alzheimer s Disease. 80(2). 775–786. 10 indexed citations
8.
Griciuc, Ana, Anthony Federico, D. McGinty, et al.. (2020). Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Human Molecular Genetics. 29(17). 2920–2935. 89 indexed citations
9.
Griciuc, Ana, Shaun R. Patel, Anthony Federico, et al.. (2019). TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease. Neuron. 103(5). 820–835.e7. 261 indexed citations
10.
Griciuc, Ana, Kaly A. Mueller, D. McGinty, et al.. (2019). Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis. Scientific Reports. 9(1). 17728–17728. 28 indexed citations
11.
Shoup, Timothy M., Marc D. Normandin, Kazue Takahashi, et al.. (2019). Fluorinated Cromolyn Derivatives for Potential Alzheimer’s Disease Treatment. 60. 114–114. 1 indexed citations
12.
Zhang, Can, Ana Griciuc, Eloïse Hudry, et al.. (2018). Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis. Scientific Reports. 8(1). 1144–1144. 72 indexed citations
13.
Quinti, Luisa, et al.. (2017). [P4–404]: A NOVEL DRUG‐SCREENING PLATFORM IN MICROGLIAL CELLS IDENTIFIES POTENTIAL AD DRUGS. Alzheimer s & Dementia. 13(7S_Part_31). 2 indexed citations
14.
Griciuc, Ana, Michel J. Roux, Juliane Merl, et al.. (2014). Proteomic Survey Reveals Altered Energetic Patterns and Metabolic Failure Prior to Retinal Degeneration. Journal of Neuroscience. 34(8). 2797–2812. 22 indexed citations
15.
Griciuc, Ana, Alberto Serrano‐Pozo, Antonio Parrado, et al.. (2013). Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta. Neuron. 78(4). 631–643. 765 indexed citations breakdown →
16.
Griciuc, Ana, Liviu Aron, & Marius Ueffing. (2011). Looking into Eyes: Rhodopsin Pathologies in Drosophila. Advances in experimental medicine and biology. 723. 415–423. 4 indexed citations
17.
Griciuc, Ana, Liviu Aron, & Marius Ueffing. (2011). ER stress in retinal degeneration: a target for rational therapy?. Trends in Molecular Medicine. 17(8). 442–451. 48 indexed citations
18.
Griciuc, Ana, Liviu Aron, Giovanni Piccoli, & Marius Ueffing. (2010). Clearance of RhodopsinP23H aggregates requires the ERAD effector VCP. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(3). 424–434. 42 indexed citations
19.
Griciuc, Ana, Liviu Aron, Michel J. Roux, et al.. (2010). Inactivation of VCP/ter94 Suppresses Retinal Pathology Caused by Misfolded Rhodopsin in Drosophila. PLoS Genetics. 6(8). e1001075–e1001075. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomomi Kiyota Breakdown of academic impact, for papers by Erin G. Reed-Geaghan Breakdown of academic impact, for papers by Nicholas H. Varvel Breakdown of academic impact, for papers by Carlo Sala Frigerio Breakdown of academic impact, for papers by Honghua Zheng Breakdown of academic impact, for papers by Michael A. Mastrangelo Breakdown of academic impact, for papers by Yuka Atagi Breakdown of academic impact, for papers by Brandy Wilkinson Breakdown of academic impact, for papers by Oscar Harari Breakdown of academic impact, for papers by Jessica Koenigsknecht-Talboo
Rankless by CCL
2026